BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20434937)

  • 1. Imaging movement-related activity in medicated Parkin-associated and sporadic Parkinson's disease.
    van Eimeren T; Binkofski F; Buhmann C; Hagenah J; Strafella AP; Pramstaller PP; Siebner HR; Klein C
    Parkinsonism Relat Disord; 2010 Jul; 16(6):384-7. PubMed ID: 20434937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.
    van Nuenen BF; van Eimeren T; van der Vegt JP; Buhmann C; Klein C; Bloem BR; Siebner HR
    Mov Disord; 2009; 24 Suppl 2():S703-10. PubMed ID: 19877238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.
    Bilgic B; Bayram A; Arslan AB; Hanagasi H; Dursun B; Gurvit H; Emre M; Lohmann E
    Parkinsonism Relat Disord; 2012 Jun; 18(5):562-6. PubMed ID: 22445249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism.
    Buhmann C; Binkofski F; Klein C; Büchel C; van Eimeren T; Erdmann C; Hedrich K; Kasten M; Hagenah J; Deuschl G; Pramstaller PP; Siebner HR
    Brain; 2005 Oct; 128(Pt 10):2281-90. PubMed ID: 15947065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.
    Tan EK; Shen H; Tan JM; Lim KL; Fook-Chong S; Hu WP; Paterson MC; Chandran VR; Yew K; Tan C; Yuen Y; Pavanni R; Wong MC; Puvan K; Zhao Y
    Neurogenetics; 2005 Dec; 6(4):179-84. PubMed ID: 16086186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.
    Chambers RP; Call GB; Meyer D; Smith J; Techau JA; Pearman K; Buhlman LM
    Behav Brain Res; 2013 Sep; 253():95-102. PubMed ID: 23871228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
    Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel ST; Ribeiro MJ; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A;
    Neurology; 2009 Jan; 72(2):110-6. PubMed ID: 18987353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations.
    Schneider SA; Talelli P; Cheeran BJ; Khan NL; Wood NW; Rothwell JC; Bhatia KP
    Mov Disord; 2008 Oct; 23(13):1812-9. PubMed ID: 18759365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
    Sharp ME; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella C; Nance M; Bressman S; Scott WK; Tanner C; Waters C; Fahn S; Cote L; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Payami H; Molho E; Factor SA; Nutt J; Serrano C; Arroyo M; Pauciulo MW; Nichols WC; Clark LN; Alcalay RN; Marder KS
    Mov Disord; 2015 Feb; 30(2):278-83. PubMed ID: 25393808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
    Anders S; Sack B; Pohl A; Münte T; Pramstaller P; Klein C; Binkofski F
    Brain; 2012 Apr; 135(Pt 4):1128-40. PubMed ID: 22434215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
    Sutherland G; Mellick G; Sue C; Chan DK; Rowe D; Silburn P; Halliday G
    Neurosci Lett; 2007 Mar; 414(2):170-3. PubMed ID: 17280783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease.
    Cerasa A; Hagberg GE; Peppe A; Bianciardi M; Gioia MC; Costa A; Castriota-Scanderbeg A; Caltagirone C; Sabatini U
    Brain Res Bull; 2006 Dec; 71(1-3):259-69. PubMed ID: 17113955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.
    Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C
    Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD.
    Machner B; Klein C; Sprenger A; Baumbach P; Pramstaller PP; Helmchen C; Heide W
    Neurology; 2010 Jul; 75(2):125-8. PubMed ID: 20625164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I; Di Fonzo A; Saladino F; Del Bo R; Bresolin N; Comi GP; Rango M
    Neurotoxicology; 2007 May; 28(3):698-701. PubMed ID: 17335904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.